PMID

Data

Article Title

Organization

Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.

University of Louisiana At Monroe

Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer.

University of Louisiana At Monroe

Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.

University of Louisiana At Monroe

Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancer.

University of Louisiana At Monroe

Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58.

University of Louisiana At Monroe

The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.

University of Louisiana At Monroe

Discovery of novel GSK-3ß inhibitors with potent in vitro and in vivo activities and excellent brain permeability using combined ligand- and structure-based virtual screening.

University of Louisiana At Monroe

Dimerization of resveratrol by the grapevine pathogen Botrytis cinerea.

University of Louisiana At Monroe

A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.

University of Louisiana At Monroe

(1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.

University of Louisiana At Monroe

The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.

University of Louisiana At Monroe

Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.

University of Louisiana At Monroe